Doctor profile · Federal record
Dr. SAMAN HAYATDAVOUDI, M.D.
Critical Care Medicine (Internal Medicine) Physician (CMS: CRITICAL CARE (INTENSIVISTS)) · Internal Medicine Physician · Pulmonary Disease Physician · SACRAMENTO, CA
- NPI 1093912958
- Accepts Medicare
- MIPS 92.4 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1508 ALHAMBRA BLVD STE 200
SACRAMENTO, CA 958166510
(916) 325-1040
fax (916) 669-4100 - Mailing address
-
1300 ETHAN WAY STE 600
SACRAMENTO, CA 958252296
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- October 19, 2020
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RC0200X — NUCC code
- State license (1)
- California #A116819
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093912958. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,589
Distinct HCPCS
10
Medicare allowed
$260,632
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 769 | 260 | $226 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 150 | 87 | $86 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 138 | 113 | $136 | |
99292 |
Critical care, each additional 30 minutes | 126 | 79 | $114 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 114 | 81 | $125 | |
94618 |
Test for exercise-induced lung stress | 69 | 62 | $36 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 57 | 57 | $174 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 56 | 55 | $96 | |
94664 |
Evaluation of use of breathing device | 39 | 38 | $19 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 38 | 36 | $96 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 75. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$949
Transactions
38
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $218.18 | |
| AstraZeneca Pharmaceuticals LP | 8 | $185.51 | |
| Actelion Pharmaceuticals US, Inc. | 4 | $117.72 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $86.66 | |
| Inspire Medical Systems, Inc. | 1 | $59.92 | |
| GENZYME CORPORATION | 1 | $39.81 | |
| Mylan Specialty L.P. | 2 | $36.13 | |
| Merck Sharp & Dohme LLC | 1 | $31.87 | |
| Insmed, Inc. | 1 | $25.31 | |
| United Therapeutics Corporation | 1 | $25.02 | |
| Amgen Inc. | 1 | $24.52 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $23.06 | |
| Baxter Healthcare | 1 | $21.80 | |
| Novartis Pharmaceuticals Corporation | 1 | $18.51 | |
| Pulmonx Corporation | 1 | $18.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
883
Patients
293
Total drug cost
$758,012
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 171 | 68 | $5,143 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 165 | 55 | $86,560 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 165 | 54 | $133,124 |
| Prednisone | Generic | 66 | 45 | $182 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 49 | 15 | $20,030 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 44 | 11 | $28,429 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 38 | 13 | $29,859 |
| Ofev (Nintedanib Esylate) | Brand | 35 | 0 | $426,897 |
| Montelukast Sodium | Generic | 30 | 0 | $360 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 30 | 16 | $2,843 |